Objective: In the present study we examined the effects of diltiazem, an L-type Ca 2+ channel blocker widely used for the control of the ventricular rate in patients with supraventricular arrhythmias, on hKv1.5 and Kv4.3 channels that generate the cardiac ultrarapid delayed rectifier (I Kur ) and the 4-aminopyridine sensitive transient outward (I to ) K + currents, respectively. Methods: hKv1.5 and Kv4.3 channels were stably and transiently expressed in mouse fibroblast and Chinese hamster ovary cells, respectively. Currents were recorded using the whole-cell patch clamp. Results: Diltiazem (0.01 nM-500 AM) blocked hKv1.5 channels, in a frequency-dependent manner exhibiting a biphasic dose-response curve (IC 50 =4.8F1.5 nM and 42.3F3.6 AM). Diltiazem delayed the initial phase of the tail current decline and shifted the midpoint of the activation (Vh=À16.5F2.1 mV vs À20.4F2.6 mV, P b 0.001) and inactivation (Vh=À22.4F0.7 mV vs À28.2F1.9 mV, P b 0.001) curves to more negative potentials. The analysis of the development of the diltiazem-induced block yielded apparent association (k) and dissociation (P) rate constants of (1.6F0.2)Â10 6 M À1 s À1 and 46.8F4.8 s
Introduction

L-type Ca
2+ channel blockers are widely used for the treatment of hypertension or coronary artery disease. Verapamil and diltiazem slow heart rate and prolong atrioventricular conduction, effects that can control the rates of ventricular response in patients with atrial arrhythmias [1] . Ca 2+ channel blockers also block several K + channels. Verapamil is a potent blocker of HERG channels that generate the rapidly activating delayed rectifier current (I Kr ), whereas diltiazem only weakly suppresses HERG current, and nifedipine has no effect [2] . Verapamil and nifedipine also block hKv1.5 channels at the low micromolar range (c20 AM) and the features of the drug-induced hKv1.5 block have been previously described in detail [3, 4] . Diltiazem, at micromolar concentrations (c115 AM), decreased Kv1.5 currents recorded in mouse erythroleukemia (MEL) cells [5] and Xenopus oocytes [6] , but detailed characteristics of diltiazem's effects have not been studied. Furthermore, it has also been described that verapamil and nifedipine block the transient outward current (I to ) in rat ventricular myocytes [7] , whereas the effects of diltiazem on either I to or Kv4.3 channels are unknown. Kv1.5 channels are highly expressed in human atria and conduct the ultra-rapid delayed rectifier current (I Kur ) that is present in atrial but not in ventricular tissue. Thus, I Kur contributes exclusively to atrial action potential repolarization [8] . Human atrial tissue also exhibits a robust 4-aminopyridine sensitive component of the transient outward current (I to1 ) [9] . Human cardiac I to1 is carried by Kv4.3 asubunits [10] , co-assembled with KChIP2s auxiliary hsubunits [11] . Therefore, both I to1 and I Kur contribute to the duration of the human atrial action potential [12] . The present study was undertaken to analyze the effects of diltiazem on hKv1.5 and Kv4.3 channels. The results demonstrated that diltiazem, at therapeutic concentrations, decreased hKv1.5 and Kv4.3 currents by binding to the open and the inactivated states of the channels.
Methods
Transmembrane action potentials
Action potentials were recorded in left atria from male ICR (CD-1) Swiss strain mice (35-40 g) perfused with Tyrode solution (34 8C) and driven at 3 Hz using microelectrode techniques [13, 14] . The investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, Revised 1996).
Cell culture
Ltk
À cells stably expressing hKv1.5 channels and CHO cells were grown in Hams-F12 with 10% fetal bovine serum in a 5% CO 2 atmosphere as previously described [13, 14] . The transient expression of Kv4.3 channels on CHO cells has been also described [14, 15] . Briefly, the cells were transfected with the cDNA encoding Kv4.3 channels (3 Ag) together with the cDNA encoding the CD8 antigen (0.5 Ag) using lipofectamine (Gibco). Before experimental use, cells were incubated with polystyrene microbeads precoated with anti-CD8 antibody (Dynabeads M450; Dynal, Norway). Most of the cells that were beaded also had channel expression [14] .
Solutions and drugs
Tyrode's solution contained (mM): NaCl 137, KCl 5.4, MgCl 2 1.0, CaCl 2 1.8, NaH 2 PO 4 0.42, NaHCO 3 
Recording Techniques
Currents were recorded at 21-23 8C using the wholecell configuration of the patch-clamp with Axopatch 200 B amplifiers and pClamp 9.0 software (Axon Instruments, Foster City, CA, USA). hKv1.5 and Kv4.3 currents were sampled at 2 and 4 kHz, respectively and filtered at half the sampling frequency. Micropipette resistance was kept b3.5 MV when filled with the internal solution and immersed in the external solution. Maximum hKv1.5 current amplitudes averaged 1.7F0.2 nA (n=20) and access resistance and cell capacitance 4.3F0.2 MV and 8.5F0.4 pF, respectively (n=20). CHO cells capacitance averaged 14.9F0.7 pF and access resistance 4.5F0.2 MV (n=20). Maximum Kv4.3 currents averaged 2.7F0.4 nA (n=10). Typically, c80% of capacitance and series resistance could be compensated, which leads to mean uncompensated access resistances of 2.6F0.4 MV and 1.7F0.1 MV for Ltk À and CHO cells, respectively. Thus, under these conditions no significant voltage errors (b5 mV) due to series resistance were expected with the micropipettes used.
Pulse protocols and analysis
The holding potential was maintained at À80 mV and the cycle time for any protocol was 10 s to avoid accumulation of inactivation and/or block. The protocol to obtain currentvoltage relationships consisted of 250 ms (Kv4.3) or 500 ms (hKv1.5) pulses that were imposed in 10 mV increments between À80 and +60 mV for hKv1.5 and between À90 and +50 mV for Kv4.3, respectively. Deactivating hKv1.5 btailQ currents were recorded on return to À40 mV. The activation curves of hKv1.5 channels were constructed by plotting tail current amplitudes as a function of the membrane potential. Voltage dependence of Kv4.3 channel activation or conductance ( G) was determined from the relationship:
where I tp is the current amplitude at the test potential (V m ) and V R is the reversal potential (À72.4F6.4 mV, n=6).
To obtain the inactivation curves of hKv1.5 and Kv4.3 channels, a two-step voltage-clamp protocol was used. The first 10-s (hKv1.5) or 250-ms (Kv4.3) conditioning pulse from À80 to potentials between À90 and +50 mV was followed by a test pulse to +60 mV (hKv1.5) or to +40 mV (Kv4.3). Inactivation curves were constructed plotting the current amplitude as a function of the voltage command of the conditioning pulse.
To describe the time course of current activation and/or inactivation upon depolarization, as well as the tail currents upon repolarization, an exponential analysis was used [13] [14] [15] .
To obtain the IC 50 (concentration of drug that produces the half-maximum blockade) and the Hill coefficient, n H , the fractional block obtained at various drug concentrations [D] was fitted to the equation:
Under some circumstances, a Hill equation with two terms was needed to fit the data, the equation being:
where the sum of B 1 and B 2 represents the total amount of block reached.
Apparent rate constants for association (k) and dissociation (l) were obtained from fitting:
where s Block is the time constant of development of block.
Statistical methods
Data obtained in the absence and the presence of diltiazem were compared in a paired manner. For comparisons at a single voltage, differences were analyzed using the Student's t-test. To analyze block at multiple voltages, two-way analysis of variance was used, followed by Newman-Keuls test. Results were expressed as mean-FS.E.M. A P-value of less than 0.05 was considered as significant. Fig. 1A shows hKv1.5 current traces recorded by applying 500-ms pulses from À80 to +60 mV in the absence and the presence of 10 nM diltiazem. At this concentration, diltiazem did not significantly modify the peak current amplitude (2.7F1.4%, n=12) and the time constant of current activation (0.9F0.1 vs. 0.9F0.1 ms, n=12, PN0.05). In control conditions one component was required to describe the time course of the slow and partial inactivation of the current (s c =145.9F17.7 ms). In the presence of diltiazem, the current decline was also fitted to a monoexponential function and diltiazem did not modify the time course of this process (s DTZ =131.4F10.1 ms, n=12, PN0.05). However, it increased the amplitude of the decaying component from 685F122 to 911F144 pA (n=12, Pb0.01). Thus, diltiazem reduced hKv1.5 currents at the end of the pulses to +60 mV by 22.8F2.1% (n=12), this effect being reversible upon washout during 5-7 min with drug-free solution (Fig. 1A) . The time course of tail currents elicited upon repolarization to À40 mV after 500-ms pulses to +60 mV was fitted by a biexponential function, the fast (s f ) and the slow (s s ) time constants averaging 20.3F3.1 and 90.6F15.6 ms, respectively (Fig.  1B) . Diltiazem slowed the tail current deactivation, increasing the s f to 26.2F3.7 ms ( Pb0.05, n=12). This effect was more marked as the drug concentration was increased, in fact; 10 AM diltiazem increased the s f to 41.6F5.5 ms ( Pb0.05, n=6), leading to a clear crossover of the tail current (Fig. 1B) .
Results
Effects of diltiazem on hKv1.5 currents
The blockade at the end of 500-ms pulses to +60 mV was used as an index of block and represented as a function of the diltiazem concentration (Fig. 1C) . The percentage of block remained almost constant for concentrations ranging from 0.01 to 1 nM, and thereafter, it increased as the concentration of diltiazem increased. However, the high affinity of diltiazem for hKv1.5 channels cannot be attributed to a time-dependent rundown of the current, since under our experimental conditions current amplitude remained unchanged during the time of recordings ( intercept with the ordinate axis for the fitted relation yielded apparent association and dissociation rate constants of (1.6F0.2)Â10 6 M À1 s À1 and 46.8F4.8 s À1 , respectively. The upper panel of Fig. 2 shows representative hKv1.5 current traces obtained in the presence and the absence of 10 nM diltiazem, and Fig. 2A the current-voltage relationship (500 ms isochronal). Diltiazem significantly decreased the current amplitude at potentials positive to À10 mV. The I DTZ /I CON ratio was plotted as a function of the membrane potential. The blockade increased steeply in the voltage range coinciding with that of channel activation (between À20 and 0 mV) and thereafter it remained constant. The hKv1.5 charge (estimated from the integral of the current traces) as a function of the membrane potential in the absence and the presence of 10 nM diltiazem was plotted in Fig. 2B . Diltiazem significantly decreased the charge at potentials positive to À10 mV (n=12, Pb0.05). The blockade increased steeply in the voltage range coinciding with that of channel activation and, thereafter, it remained constant. Furthermore, blockade of the charge at +60 mV (18.6F1.4%, n=12, PN0.05) was not statistically different from the blockade measured at the end of the pulse. When the decrease in the charge at +60 mV was used as an index of block, the IC 50 values obtained for the biphasic curve (open symbols in Fig. 1C ) averaged 28.7F2.9 nM and 63.7F9.8 AM, respectively, whereas the IC 50 obtained for the monophasic curve averaged 20.2F6.8 AM (n H =0.8F0.2). Fig. 2C shows the activation curves in the absence and the presence of 10 nM diltiazem. Under control conditions, the activation curve yielded V h and k values of À16.5F2.1 and 4.3F0.5 mV, respectively (n=12). Diltiazem decreased the tail current amplitude at potentials positive to 0 mV (16.9F2.4% at +60 mV, Pb0.05) and shifted the V h to more negative potentials (À20.4F2.6 mV, Pb0.001) without modifying the k value (3.9F0.5 mV, PN0.05). Fig. 2D shows the effects of diltiazem on the voltage dependence of hKv1.5 channels slow inactivation. Diltiazem shifted the half-inactivation voltage from À22.4F0.7 to À28.2F1.9 mV (n=9, Pb0.001) without modifying the slope of the curve (k=3. peak (s act =0.9FF0.1 ms, n=10), and then inactivated following a biexponential process (s f =19.2F2.3 ms and s s =54.5F9.9 ms at +50 mV, n=5). Diltiazem 10 nM decreased the peak current by 23.3F3.5% (n=5, Pb0.05) but, at this concentration, did not modify the time course of current decay (s f =18.3F2.0 ms and s s =58.7F7.1 ms, n=5, PN0.05). The effects of diltiazem on Kv4.3 channels were reversible upon superfusion with drug-free external solution for 7-10 min (Fig. 3A) . Fig. 3B shows Kv4.3 traces obtained in the presence of increasing diltiazem concentrations. As the concentration increased, the peak current amplitude decreased, and at concentrations z0.1 AM, diltiazem accelerated the time course of current decay. In fact, at 0.1 AM, diltiazem s f decreased from 20.4F2.7 to 14.9F1.6 ms (n=5, Pb0.05). Fig. 3C shows the concentration-response curve obtained by plotting the peak reduction at +50 mV as a function of the diltiazem concentration. The solid line represented the fit to a single Hill equation (IC 50 =97.7F 15.1 AM, n H =0.7F0.1). However, the actions of diltiazem at concentrations z0.1 AM are suggestive of an open-channel block, and thus, the reduction of peak current would not represent the steady-state block. Therefore, diltiazeminduced block was also measured as the reduction of the total charge crossing the membrane estimated from the integral of the current traces elicited at +50 mV. Using this index of block, the data clearly deviated from the continuous line which represented the fit to a Hill equation of a single component (IC 50 =22.9F9.9 AM, n H =0.4F0.1) because the concentration-response exhibited two components described by two IC 50 values that averaged 62.6F11.1 nM and 109.9F12.8 AM, respectively. The high affinity of diltiazem for Kv4.3 channels cannot be attributed to a time-dependent rundown of the current, since current amplitude remained unchanged during the time of recordings (Fig. 3D) .
To assess the onset block kinetics, the ratio between diltiazem-sensitive current during the pulse to +50 mV and the current in control conditions [(I C ÀI DTZ )/I C ] was calculated for all the concentrations tested. As can be observed in Fig. 3E , blockade increased during the application of the pulse. The onset of block was fitted by a monoexponential function (solid curve) to determine the s Block , which at 0.1 AM averaged 10.1F3.2 ms (n=7). Fig.  3F shows the plot of the 1/s Block as a function of the diltiazem concentration for data obtained at concentrations in the range 0.1-500 AM. The straight line is the leastsquares fit to Eq. (4) and the apparent association and dissociation rate constants resulted (1.7F0.2)Â10 6 M À1 s
À1
and 258.6F38.1 s À1 , respectively. The upper part of Fig. 4 shows Kv4.3 current traces obtained in the presence and the absence of 10 nM diltiazem with the protocol described in Methods. In Fig. 4A , the peak current-voltage relationship, demonstrated that diltiazem significantly decreased the Kv4.3 current at potentials N0 mV. Furthermore, as derived from the fractional block represented as a function of the membrane potential, the blockade steeply increased in the voltage range of channel activation, reaching a 24.9F1.4% at 10 mV and, thereafter, it remained constant. The Kv4.3 charge as a function of the membrane potential in the absence and the presence of 0.1 AM diltiazem was plotted in Fig. 4B . At concentrations z0.1 AM, diltiazem significantly decreased the charge at potentials positive to À10 mV (n=6, Pb0.05). The fractional charge block remained unchanged at potentials between À20 and +50 mV (35.0F6.3% at À20 mV vs. 33.8F2.4 at +50 mV, n=6, PN0.05). Fig. 4C shows the conductancevoltage curves of Kv4.3 channels in the absence and the presence of 10 nM diltiazem. Conductance was determined from the peak current amplitude elicited with 250-ms pulses from À80 mV to potentials ranging À60 and +50 mV, corrected for changes in the driving force with the mean reversal potential (Eq. the preceding pulse, demonstrating that the blockade remained unchanged at potentials between À90 mV (22.7F4.9%) and À60 mV (25.5F6.0%, n=6, PN0.05). At more positive potentials, it augmented as the amount of inactivated channels increased, reaching a maximum at À30 mV (57.2F11.8%, Pb0.05 vs. blockade at À90 mV).
3.3. Frequency-dependent effects of diltiazem on hKv1.5 and Kv4.3 channels
To evaluate whether the blockade of hKv1.5 and Kv4.3 channels increased under conditions of repetitive stimulation trains of 16 pulses to +60 mV were applied in the absence and the presence of 10 nM diltiazem (Fig. 5A and  B) . During the train 200-ms pulses were applied at 1 or 2 Hz, whereas 100-ms pulses were applied at 5 Hz. Trains were separated from each other by 2-min intervals. Peak current amplitude decreased under control conditions because of the accumulation of the slow (hKv1.5) and fast (Kv4.3) inactivation. Fig. 5A and B shows the ratio of the peak hKv1.5 and Kv4.3 current amplitudes in the presence of diltiazem (I DTZ /I con ) as a function of the number of pulse during trains. A certain amount of block was apparent from the first depolarization applied, i.e., btonic blockQ (Table 1) . Thereafter, during the train, the blockade increased until a steady state was achieved (Table 1 , Fig. 5A and B) . The onset kinetics of the frequency-dependent block was analyzed by fitting the relative current against the number of consecutive pulses of the trains (continuous lines) to a monoexponential function, the rate constants of the onset kinetics (K) being summarized in Table 1 . These results indicated that under conditions of repetitive stimulation the diltiazem-induced block of hKv1.5 and Kv4.3 channels significantly increased.
Effects on transmembrane action potentials
The effects of 10 nM diltiazem on the action potentials recorded in isolated mouse atria were also examined. Fig.  6A shows action potentials recorded in the absence and the presence of diltiazem. Diltiazem did not modify the resting membrane potential (À80.7F1.6 mV) or the action potential amplitude (104F0.8 mV, n=6). In contrast, diltiazem slightly, but significantly, lengthened the action potential duration measured at 50% and 90% of repolarization (Fig. 6B ).
Discussion
We have analyzed the effects of diltiazem on two K + currents involved in human atrial repolarization. Therapeutic plasma concentrations obtained after administration of slow and fast release formulations of diltiazem (120 mg) were 0.11-0.33 AM [16] . Considering that diltiazem is highly bound to plasma proteins (c80%), the free plasma concentration would be 22-66 nM. Thus, this study demonstrated for the first time that, at therapeutic concentrations, diltiazem blocked hKv1.5 and Kv4.3 channels.
4.1. Concentration-dependent effects of diltiazem on hKv1.5 and Kv4.3 channels
The effects of two micromolar concentrations of diltiazem on Kv1.5 channels expressed in MEL cells were previously studied, but the concentration-, time-and voltage-dependent characteristics of the blockade were not described [5] . More recently, it has been described that 100 AM diltiazem decreased Kv1.5 currents recorded in Xenopus oocytes by 15% [6] . However, in oocytes much higher concentrations of lipophilic drugs are needed to block expressed channels [6] . On the other hand, the effects of diltiazem on either I to or Kv4.3 are unknown. Our results demonstrated that diltiazem exhibited a high affinity for hKv1.5 and Kv4.3 channels and that the blockade of these cardiac K + channels would appear at the same concentrations needed to block L-type Ca 2+ channels [16] . Surprisingly, the concentration-response curve of diltiazem in both channels exhibited two components. This could be explained by the existence of two different populations of channels with different affinities for diltiazem on the cell expression system used. hKv1.5 channels were studied in stably transfected Ltk À cells and Kv4.3 on transiently transfected CHO cells, and no evidence was obtained for non-homogeneous channel populations when examining the effects of other drugs on these channels under the same experimental conditions [14, 15, 17] . It is also possible that two separated binding sites with different affinities would exist both on hKv1.5 and Kv4.3 channels. The existence of two separated binding sites for drugs on hKv1.5 channels has recently been proposed [17] . Furthermore, some results demonstrated the presence of an intracellular [18] and an extracellular binding site for local anesthetics in these channels [19] . Another possibility is that more than one diltiazem molecule would access the pore to block the K + efflux, but probably when the concentration of bulky molecules of diltiazem near the binding site increases, the steric hindrance interactions between them would decrease the efficacy of block [15] . Therefore, although previous explanations can account for this result, further analysis at the single channel level is necessary to clarify this issue. Finally, even when diltiazem contains two adjacent chiral centres, thus existing as four stereoisomers, in this study we evaluate the effects of (2S,3S)-cis-diltiazem, which is the enantiomer used in therapeutics [16] . Therefore, the biphasic curve cannot be attributed to the separated interaction, with different affinities, of the diltiazem enantiomers with either the hKv1.5 or the Kv4.3 channel proteins. Finally, it should be stressed that the concentrations of verapamil and nifedipine required for inhibition of hKv1.5 (IC 50 =20 and 6.3 AM, respectively) [ Diltiazem induced a voltage-dependent block of hKv1.5 and Kv4.3 channels that increased at the voltage range of channel activation. At potentials at which channel activation reached saturation, diltiazem-induced block remained constant. This result differentiates diltiazem from verapamil and nifedipine, whose hKv1.5-blockade increased and decreased, respectively, at the same voltage range [3, 4] . Diltiazem induced block of both hKv1.5 and Kv4.3 channels developed during the depolarization and no block was apparent before the channels opened. The voltage dependence and the development kinetics of block strongly suggest that diltiazem blocks the open state of both channels. Furthermore, diltiazem slowed the tail current decline and induced a frequency-dependent block of hKv1.5 and Kv4.3 channels, and accelerated the Kv4.3 current inactivation, results that strongly support the proposed openstate interaction for both channels.
Using the time constants of development of hKv1.5-block obtained in the range 0.1-500 AM, the k and l constants for diltiazem were obtained. Assuming a firstorder reaction drug/channel interaction, the ratio l/k would give the apparent IC 50 of 29.2 AM. This estimate was independent but similar to the IC 50 calculated from the concentration-response curve. In the case of Kv4.3 channels, the ratio l/k yielded an apparent IC 50 (152 AM), which is also similar to that obtained from the concentration-response curve. The similarity of the IC 50 values obtained by the two independent methods supports the open-channel block model used to calculate the rate constants in each channel. Furthermore, the results indicated that the apparent rate constant of association of diltiazem was very similar for both channels, whereas the dissociation process was slower in Kv4.3 compared with hKv1.5 channels, which explains the somewhat lower affinity of diltiazem for the latter.
Finally, diltiazem modified the voltage dependence of hKv1.5 and Kv4.3 channel inactivation and, in Kv4.3 channels the blockade significantly augmented with channel inactivation. These results suggested that diltiazem also binds to the inactivated state of hKv1.5 and Kv4.3 channels. Affinity for both the open and the inactivated state has been previously described for flecainide and quinidine on Kv4.2 [22] and for irbesartan on Kv4.3 channels [15] .
Clinical implications
In anesthetized dogs, despite similar effects on blood pressure, PR interval and intra-atrial conduction, diltiazem did not share verapamil's ability to decrease the atrial effective refractory period or the atrial fibrillation cycle length and did not promote atrial fibrillation [23] . These differences could be explained because verapamil and diltiazem exhibited a different blocking profile of Ca 2+ and/or K + channels [24] . Here we demonstrated that, at room temperature (a possible limitation of the study), diltiazem blocks Kv4.3 and hKv1.5 channels, the latter being present only in the atria [8] . In contrast, previous reports demonstrated that verapamil is a weak blocker of hKv1.5 and Kv4.3 channels (at the low micromolar range), but a potent blocker of HERG channels [2, 3] . The effects of nanomolar concentrations of diltiazem on hKv1.5 and on Kv4.3 are moderate but are likely to be enhanced during tachyarrhythmias due to the frequency dependence of its action. Speculatively, blockade of Kv1.5 and Kv4.3 currents in the human atria could attenuate the shortening of the action potential duration caused by the inhibition of L-type Ca 2+ channels by diltiazem. In fact, we demonstrated that 10 nM diltiazem (a concentration somewhat lower than the free plasma concentrations reported in humans) lengthened the atrial action potentials in mice. These effects can be explained by the blockade of I to and I Kslow that contributed to the repolarization in mouse heart and are generated by Kv4.2 and Kv1.5 channels, respectively [25] . Thus, these K + channel-blocking properties exhibited by diltiazem could protect against an atrial fibrillation-promoting effect and raise the question of whether diltiazem might be a better choice than verapamil for rate control among patients with atrial fibrillation in whom a subsequent cardioversion is considered [24] .
